We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+66.45%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$2.11B
AUM Growth
+$907M
Cap. Flow
+$316M
Cap. Flow %
14.95%
Top 10 Hldgs %
69.55%
Holding
49
New
3
Increased
4
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
SPT icon
Sprout Social
SPT
+$147M
2
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
+$104M
3
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
+$53.2M
4
LITS
Lite Strategy Inc
LITS
+$5.23M
5
ARDX icon
Ardelyx
ARDX
+$4.86M

Top Sells

Rank Stock Value
1
KA
Kineta, Inc. Common Stock
KA
+$4.7M
2
AKAO
Achaogen Inc
AKAO
+$63K

Sector Composition

Rank Sector Weight
1 Healthcare 86.26%
2 Technology 10.64%
3 Industrials 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSBR icon
26
Champions Oncology
CSBR
$75M
$13M 0.62%
1,562,500
– –
XENE icon
27
Xenon Pharmaceuticals
XENE
$6B
$13M 0.62%
992,107
+389,444
+65% +$4.1M
TPST icon
28
Tempest Therapeutics
TPST
$14.1M
$11.9M 0.56%
9,060
– –
SYBX
29
DELISTED
Synlogic
SYBX
$10.9M 0.52%
281,961
– –
LQDA icon
30
Liquidia Corp
LQDA
$7.42B
$10.6M 0.5%
2,486,062
– –
BE icon
31
Bloom Energy
BE
$64.5B
$9.96M 0.47%
1,333,333
– –
LXRX icon
32
Lexicon Pharmaceuticals
LXRX
$1.02B
$9.89M 0.47%
2,382,286
– –
SBBP
33
DELISTED
Strongbridge Biopharma plc.
SBBP
$8.66M 0.41%
4,141,308
– –
DZSI
34
DELISTED
DZS Inc. Common Stock
DZSI
$8.47M 0.4%
956,255
– –
VRNA
35
DELISTED
Verona Pharma
VRNA
$7.01M 0.33%
1,219,674
– –
RIGL icon
36
Rigel Pharmaceuticals
RIGL
$683M
$6.94M 0.33%
324,315
– –
SURF
37
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$6.23M 0.29%
3,315,149
– –
CTIC
38
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$5.83M 0.28%
3,750,000
– –
PHXM
39
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$4.61M 0.22%
62,500
– –
XFOR icon
40
X4 Pharmaceuticals
XFOR
$378M
$3.57M 0.17%
11,111
– –
TRVN
41
DELISTED
Trevena, Inc.
TRVN
$3.21M 0.15%
6,099
– –
TRIL
42
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.16M 0.1%
2,100,000
– –
RGLS
43
DELISTED
Regulus Therapeutics
RGLS
$1.83M 0.09%
205,246
– –
TCON
44
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$811K 0.04%
17,336
– –
AKTX
45
Akari Therapeutics
AKTX
$12.6M
$791K 0.04%
565
– –
VIRX
46
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$438K 0.02%
37,094
– –
ELGX
47
DELISTED
Endologix Inc
ELGX
$393K 0.02%
249,021
– –
KA
48
DELISTED
Kineta, Inc. Common Stock
KA
– –
-39,691
Closed -$4.7M
AKAO
49
DELISTED
Achaogen Inc
AKAO
– –
-5,215,128
Closed -$63K
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return

NEA Management Company's Q4 2019 Portfolio in Review

As of Q4 2019, NEA Management Company held 49 positions worth $2.11B, up 75% from $1.21B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

NEA Management Company deployed $316M of net new capital in Q4 2019, opening 3 new positions and adding to 4 existing holdings. Its largest new stake was Sprout Social: 9,046,080 shares worth $145M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 91% a quarter earlier, followed by Technology and Industrials.

On the sell side, the most notable exit was Kineta, Inc. Common Stock, an estimated $4.7M sold.

  • NEA Management Company's largest Q4 2019 buy was Sprout Social: 9,046,080 shares worth $145M.
  • NEA Management Company added most to Lite Strategy Inc in Q4 2019, an estimated $5.23M increase.
  • NEA Management Company fully exited Kineta, Inc. Common Stock in Q4 2019, selling an estimated $4.7M.
  • NEA Management Company's ten largest holdings make up 70% of its $2.11B portfolio in Q4 2019.
  • NEA Management Company opened 3 new positions and closed 2 in Q4 2019.
  • NEA Management Company's portfolio value rose 75% quarter-over-quarter to $2.11B.

Based on NEA Management Company's 13F filing for Q4 2019, filed 24 Jan 2020.